Institut Catala de la Salut

Barcelona

0 studies enrolling now · 1 studies all time

What they study most

Gastric Adenocarcinoma

Studies at this site

• Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma — Completed